Anesiva Files NDA For Zingo Topical Anesthetic
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm is initially seeking a pediatric indication for needle-free system but plans to expand label to include adults following completion of Phase III trial.
You may also be interested in...
Anesiva’s Fast-Acting Analgesic Zingo Clears FDA Ahead Of User Fee Date
The company is seeking a U.S. partner to aid in the launch of its first drug, CEO says.
Anesiva’s Fast-Acting Analgesic Zingo Clears FDA Ahead Of User Fee Date
The company is seeking a U.S. partner to aid in the launch of its first drug, CEO says.
Pharmos’ Synthetic Cannabinoid Disappoints In Phase IIa
Company will study oral cannabinor for neuropathic pain, adjust intravenous dosing for nociceptive pain.